Results 81 to 90 of about 4,742 (202)
Consensus‐based follow‐up and treatment registry for GNAO1‐associated disorder
Developmental Medicine &Child Neurology, EarlyView.Abstract Aim To establish consensus‐based recommendations on relevant domains of functioning and assessment instruments for an GNAO1‐associated disorder follow‐up and treatment registry. Method This was a mixed‐methods study consisting of a systematic literature search, a survey, and a real‐time Delphi procedure to achieve consensus on domains and ...
Larissa R. Heideman +9 more
wiley +1 more source
Holy vikings: Saints' lives in the old Icelandic kings' sagas
, 2007 The biographies of royal saints in the Old Icelandic kings’ sagas are usually described as “secular” or “profane” texts and not “proper” saints’ lives. This book argues that theoretical concepts developed by Mikhail Bakhtin can provide new insights into ...
Phelpstead, Carl Luke
core
Developmental Medicine &Child Neurology, EarlyView.Aim To examine longitudinal changes in speech and gross motor function in children with cerebral palsy (CP) between 4 years and 14 years of age using the Viking Speech Scale (VSS) and the Gross Motor Function Classification System (GMFCS). Method In this longitudinal observational study, 44 children (26 male, 18 female) with CP were assessed at ages 4 ...
Sydney A. Jensen, Katherine C. Hustad
wiley +1 more source
The Vikings, victims of their own success?
Danish Journal of Archaeology, 2015 The Viking age as a time of adventures and violence never ceases to fascinate the public. Both aspects remain central to the definitions of the period which can be found in recent introductions to the topic.
Sarah Croix
doaj +1 more source
Vikingens framstilling i Vikings [PDF]
Hvordan framstilles vikingen i dagens populærkultur? Vikingen har lenge hatt en mindre heldig framstilling i populærkultur, ofte som skitne, uintelligente og barbariske. Er denne framstillingen noe man ser i dag?
Bleken, Herman Vedal
core
Diabetes, Obesity and Metabolism, EarlyView.ABSTRACT Aims This study aimed to indirectly compare the effects of oral semaglutide 25 mg versus orforglipron 36 mg on body weight loss, other cardiometabolic biomarkers, and tolerability in adults with overweight (body mass index [BMI] ≥ 27 kg/m2 and at least one obesity‐related complication) or obesity (BMI ≥ 30 kg/m2), without diabetes, using data ...
Wojciech Michalak +7 more
wiley +1 more source
Diabetes, Obesity and Metabolism, EarlyView.ABSTRACT Aims This prespecified analysis evaluated whether the safety and efficacy of finerenone and a sodium–glucose cotransporter 2 inhibitor (SGLT2i) combination vary by baseline glycated haemoglobin (HbA1c). Materials and Methods Adults with type 2 diabetes and a urinary albumin‐to‐creatinine ratio (UACR) of 100 − < 5000 mg/g, estimated glomerular ...
Janet B. McGill +15 more
wiley +1 more source
Journal of Functional Morphology and Kinesiology, 2019 Background: To compare load–velocity and load–power relationships among first grade (n = 26, age 22.9 ± 4.3 years), academy (n = 23, age 17.1 ± 1.0 years), and scholarship (n = 16, age 15.4 ± 0.5 years) Super League rugby ...
John F. T. Fernandes +3 more
doaj +1 more source
Diabetes, Obesity and Metabolism, EarlyView.ABSTRACT Aims Tirzepatide is a once‐weekly glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonist (RA) approved for weight management in adults with obesity. Data on older adults remain limited, however. This study aimed to examine tirzepatide's safety and efficacy in adults aged ≥ 65 years with obesity ...
Nasreen Alfaris +6 more
wiley +1 more source